According to Lumos Pharma's latest financial reports the company's current EPS (TTM) is -$8.27. In 2022 the company made an earnings per share (EPS) of -$8.12 a decrease over its 2021 EPS that were of -$6.34.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$7.72 | -4.84% |
2022 | -$8.12 | 27.98% |
2021 | -$6.34 | 305.62% |
2020 | -$1.56 | -90.26% |
2019 | -$16.06 | -29.48% |
2018 | -$22.77 | -38.72% |
2017 | -$37.16 | -20.07% |
2016 | -$46.49 | 111.51% |
2015 | -$21.98 | -137.77% |
2014 | $58.19 | -396.77% |
2013 | -$19.61 | 10.71% |
2012 | -$17.71 | 6.4% |
2011 | -$16.64 |